GO
Loading...

Midday movers: Apple, Netflix, Lowe's & More

A trader works on the floor of the New York Stock Exchange.
Getty Images
A trader works on the floor of the New York Stock Exchange.

Take a look at some of Friday's midday movers:

Ann - The women's clothier climbed after its second-quarter revenue forecast beat consensus views.

Apple - The iPhone maker rose after Goldman Sachs raises its price target to $720 from $635 while maintaining its buy rating.

Avery Dennison - The producer of pressure-sensitive materials advanced after JPMorgan upgraded it to overweight from neutral, based on valuation.

Infoblox - The network-equipment maker plunged after forecasting a lower-than-expected profit for the current quarter.

Lowe's Companies - The home-improvement retailer came off its lows after hiking its quarterly dividend nearly 28 percent to 23 cents a share.

Mack-Cali Realty - The real estate investment trust declined after cutting its quarterly dividend 50 percent to 15 cents a share.

Madison Square Garden - The sports, entertainment and media company rose as its New York Rangers hockey team got into the Stanley Cup finals. The proposed sale of the Los Angeles Clippers for $2 billion to former Microsoft CEO Steve Ballmer also helped move the stock higher.

Men's Wearhouse - The retailer and Jos. A Bank Clothiers both rose on a Dow Jones report that the Federal Trade Commission would likely approve their merger.

Michael Kors Holdings - The apparel retailer rose after Canaccord Genuity repeated a buy rating and $123 price target, saying its recent stock weakness is creating a buying opportunity.

Netflix - The online provider of internet programming continued to move higher after bullish comments from CEO Reed Hastings at the re/code conference on Thursday.

Newlink Genetics - The drug developer gained after reporting data from a mid-stage trial of its experimental cancer drug showed positive results.

NPS Pharmaceuticals - The rare disease specialist jumped after a Financial Times blog reported London-listed drugmaker Shire was considering a cash offer for the New Jersey-based company.

NQ Mobile - The Chinese mobile security software maker gained after raising its first-quarter revenue forecast.

Retrophin - The pharmaceutical company rose after licensing marketing rights for a rare kidney disease drug from privately held Mission Pharmacal and hiking its revenue forecast for 2014 and 2015.

(Read More: See CNBC's Market Insider Blog)

—By CNBC's Rich Fisherman.

Questions? Comments? Email us at marketinsider@cnbc.com

Symbol
Price
 
Change
%Change
NQ MOBILE
---
RTRX
---
NPSP
---
SHP
---
NFLX
---
NLNK
---
MIKE KORS HO
---
MW
---
JC1
---
MSG
---
CLI
---
LOW
---
BLOX
---
ANN
---
AAPL
---
AVY
---

Featured

  • Patti Domm

    Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • A CNBC reporter since 1990, Bob Pisani covers Wall Street from the floor of the New York Stock Exchange.

  • CNBC Senior Commodities Correspondent and Personal Finance Correspondent

  • JeeYeon Park is a writer for CNBC.com. Follow her on Twitter: @JeeYeonParkCNBC

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Senior Producer at CNBC's Breaking News Desk.